Explore 3 Stock Ideas & Industry Insights Download Free Report

Relevium Technologies Inc

Company price
None CAD 0.00(0%)
Last update at 2024-02-03T11:36:17.266479Z
Market Cap
6.66M

Momentum Score

…

Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.02
Low
40.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
37.00
Dividend Yield
-
Revenue TTM
14.25M
Revenue Per Share
0.05
Gross Profit TTM
0.31M
Debt / Equity
-
ROE
-426.47%
Net Debt
3.13M
ROCE
30.39%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Type yearly yearly yearly yearly yearly
Date 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Income before tax -5.37M -6.93M -3.73M -2.89M -2.58M
Net income -5.37M -6.93M -3.73M -2.89M -2.58M
Selling general administrative 1.89M 3.96M 5.30M 4.28M 1.73M
Gross profit 0.41M 1.19M 2.19M 2.28M 0.00M
Reconciled depreciation 0.00M 0.00M 0.15M 0.15M 0.07M
Ebit - -2.92M -3.26M -2.01M -1.80M
Ebitda -4.61M -6.36M -3.18M -1.95M -2.48M
Operating income -1.48M -2.77M -3.26M -2.15M -1.80M
Other operating expenses - - - - 0.06M
Interest expense 0.75M 0.57M 0.40M 0.00M 0.00M
Interest income - - - - 0.00M
Net interest income -0.75M -0.57M -0.46M -0.86M -0.03M
Non recurring - - - - 0.58M
Income tax expense - - - 0.00M 0.00M
Total revenue 0.91M 2.97M 4.05M 4.15M 0.00M
Total operating expenses 2.39M 5.75M 7.31M 6.30M 1.80M
Cost of revenue 0.50M 1.78M 1.86M 1.87M 0.00M
Total other income expense net -3.14M -3.59M -0.01M 0.11M -0.75M
Net income from continuing ops -5.37M -6.93M -3.73M -2.89M -2.58M
Net income applicable to common shares - -6.93M -3.73M -2.89M -2.58M
Breakdown 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Type yearly yearly yearly yearly yearly
Date 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Total assets 0.76M 4.33M 8.56M 8.58M 7.12M
Intangible assets 0.57M 3.32M 4.47M 3.46M 0.00M
Other current assets - - 0.07M - 0.00M
Total liab 5.66M 4.07M 3.51M 3.47M 4.79M
Total stockholder equity -4.90M 0.27M 5.05M 5.11M 2.32M
Other current liab - 0.24M - 0.15M 0.65M
Common stock - 14.07M 13.37M 10.74M 5.18M
Capital stock 14.18M 14.07M 13.37M - -
Retained earnings -23.82M -18.45M -11.52M -7.69M -4.79M
Other liab - 0.08M 0.20M 0.11M -
Good will 0.00M 0.21M 2.28M 2.28M -
Other assets - - - - 6.08M
Cash 0.06M 0.19M 0.88M 2.08M 0.90M
Total current liabilities 5.61M 4.20M 1.34M 3.36M 1.29M
Net debt 3.13M 2.62M 1.87M 0.79M -
Short term debt - - 0.77M 2.86M 0.03M
Short long term debt 3.20M 2.81M 0.77M 2.86M 0.03M
Other stockholder equity - 3.02M 1.78M 0.76M 1.70M
Property plant equipment - 0.01M 0.01M 0.02M -
Total current assets 0.18M 0.79M 1.80M 2.83M 1.04M
Net tangible assets - -3.48M -1.70M -0.62M 2.32M
Short term investments 0.01M 0.01M 0.01M 0.01M 0.01M
Net receivables 0.17M 0.38M 0.16M 0.14M 0.12M
Long term debt - - 1.97M - 3.50M
Inventory 0.04M 0.13M 0.56M 0.35M 0.00M
Accounts payable - 1.39M 0.57M 0.35M 0.61M
Non currrent assets other - - 6.76M 5.75M 6.08M
Non current assets total 0.58M 3.54M 6.76M 5.75M 6.08M
Breakdown 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Type yearly yearly yearly yearly yearly
Date 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Investments 0.00M -0.28M -0.35M -0.31M -2.56M
Change to liabilities - 0.82M 0.22M -0.26M 0.21M
Total cashflows from investing activities - -0.28M -0.35M -0.31M -2.54M
Net borrowings - -0.16M 1.01M 1.34M 2.10M
Total cash from financing activities -0.00M 1.76M 2.36M 3.84M 4.69M
Change to operating activities - 0.04M 0.13M -0.25M 0.02M
Net income -5.37M -6.93M -3.73M -2.89M -2.58M
Change in cash -0.13M -0.68M -1.20M 1.17M 0.86M
Begin period cash flow 0.19M 0.88M 2.08M 0.90M 0.05M
End period cash flow 0.06M 0.19M 0.88M 2.08M 0.90M
Total cash from operating activities -0.13M -2.16M -3.21M -2.36M -1.29M
Issuance of capital stock 0.09M 0.40M 1.18M - -
Depreciation 0.00M 0.00M 0.15M 0.15M 0.07M
Other cashflows from investing activities - -0.27M -0.07M -0.07M -0.07M
Change to inventory 0.09M 0.43M -0.22M -0.15M 0.02M
Change to account receivables - -0.37M -0.02M -0.02M -0.03M
Sale purchase of stock - - - - 1.50M
Other cashflows from financing activities - 1.45M 0.36M 0.36M 1.09M
Change to netincome - 3.85M 0.19M 1.01M 1.01M
Capital expenditures 0.00M 0.00M 0.00M 0.02M 0.02M
Change in working capital 1.51M 0.92M 0.12M -0.68M 0.22M
Stock based compensation 0.05M 0.03M 0.03M - -
Other non cash items 0.69M 0.57M 0.15M 0.36M 0.22M
Free cash flow -0.13M -2.17M -3.42M -2.45M -1.29M

Peer Comparison*

Sector: Healthcare Industry: Pharmaceutical Retailers

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HITI
High Tide Inc
0.13
3.41%
3.94 - 45.05 0.46 3.36 0.65 10.91
PCRX
PharmaCorp Rx Inc.
-0.01
1.22%
0.41 20.50 41.49 2.78 1.65 2.77 41.56

Profile*

Relevium Technologies Inc

Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.

1000 Sherbrooke Street West, Montreal, QC, Canada, H3A 3G4

888 528 8687

Name Title Year Born
Mr. Aurelio Useche C.M.A., M.B.A. Pres, CEO & Director 1968
Mr. Mark Anthony Billings C.F.A., CFA, M.B.A., MBA Chief Financial Officer 1970
Mr. Edward Ierfino B. Comm. Mang. of Investor Relations 1968
Mr. Abis Hussain Sr. Marketing Officer NA
Mr. David A. Johnson Corp. Sec. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…